In comparison, genetic inactivation of the proximal FA pathway appears to occur infrequently in tumors among the general population and has, in terms of GI cancers, yet only been reported in pancreatic cancer, where it was associated with rare mutations in FANCC or FANCG [19,20]. This evidence concerns the gene FANCG and familial pancreatic carcinoma.